Inventor
STEFAN MILTENYI
Inventor
DE
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes18%
C12NMicroorganisms or enzymes12%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
B01LChemical or physical laboratory apparatus for general use9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
A61MDevices for introducing media into, or onto, the body8%
C12MApparatus for enzymology or microbiology7%
B01DSeparation6%
B03CMagnetic or electrostatic separation of solid materials from solid materials or fluids6%
B04BCentrifuges6%
PatentTitleYear
12,576,148Engineered immune effector cells for cancer immunotherapy that are resistant to fratricide by virtue of having genetically modified surface antigens202612,560,540Method for single molecule localization microscopy202612,521,434Hematopoietic cells with a modified CD antigen for reducing side effects of cancer immunotherapy202612,498,374Method for manufacturing a patient specific cell population using a multifunctional self-contained apparatus and tubing set202512,365,718Compositions and methods for treating cancer with DuoCARs202512,318,569Sterile connector202512,318,446Reducing side effects of immunotherapy using genetically modified hematopoietic cells202512,246,065Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen202511,999,980Non-specific nucleases from the genus 202411,933,787Devices and disposables for patient-specific cell therapy manufacturing202411,883,494Combination of immune effector cells specific for a target antigen and hematopoietic calls that express the target antigen in an altered form202411,802,142Compositions and methods for treating cancer with DuoCARs202311,633,584Sterile connector202311,531,031Single use tubing set for making genetically modified donor cells for reinfusion into a patient202211,499,977Equipment and procedure for culturing, separating, and genetically modifying donor cells for reinfusion into a patient202211,499,976Device and procedure for producing a cellular pharmaceutical product enriched in genetically modified target cells at the bedside or in a surgical room202211,453,712Compositions and methods for treating cancer with DuoCARs202211,419,935Immunotherapy method comprising administering a combination of immune effector cells and non-target hematopoietic cells202211,360,025Automated analysis tool for biological specimens202211,339,407Systems and methods for point/center-of-care immunotherapy202211,208,455Compositions and methods for treating cancer with DuoCARs202111,161,111Multilevel disposable cartridge for biological specimens2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to MILTENYI BIOTEC BV & CO KG (15)· patent assignee history
2021–2026Patents assigned to MILTENYI BIOTEC GMBH (6)· patent assignee history
2021–2025Patents assigned to LENTIGEN TECH INC (4)· patent assignee history
2021–2026Based in DE· patent location history
2025Patents assigned to MILTENYI BIOTEC B V &CO KG (1)· patent assignee history
2026Patents assigned to LAVISION BIOTEC GMBH (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MILTENYI BIOTEC BV & CO KG | 15 | 2021–2026 |
| MILTENYI BIOTEC GMBH | 6 | 2021–2026 |
| LENTIGEN TECH INC | 4 | 2021–2025 |
| LAVISION BIOTEC GMBH | 1 | 2026 |
| MILTENYI BIOTEC B V &CO KG | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 22 | 2021–2026 |